Table 4 Clinical and anatomopathological characteristics of the studied groups.

From: Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer

Characteristic

EC patients (N = 57)

Reference women (N = 30)

P-valuea

Age (median (range))

65.97 (34.50–86.50)

56.71 (36.00–78.00)

NS

Body mass (kg) (median (range))

81.66 (54.00–138.00)

72.31 (48.00–108.00)

 < 0.05

Menopausal status (N (%))

  

 < 0.001

Premenopausal

4 (4.50%)

10 (33.30%)

 

Postmenopausal

53 (95.50%)

20 (67.70%)

 

FIGO stage (N (%))

 I

39 (68.00%)

  

 II

5 (9.00%)

  

 III

12 (21.00%)

  

 IV

1 (2.00%)

  

Cancer grade (N; %)

 1

18 (32.00%)

  

 2

25 (43.00%)

  

 3

14 (25.00%)

  

Histology (N (%))

 Endometrioid

50 (88.00%)

  

 Non-endometrioid

7 (12.00%)

  
  1. aP values are shown for the χ2 test (categorical variables) and Mann–Whitney U test (continuous variables); FIGO, The International Federation of Gynecology and Obstetrics; Grading: 1–5% or less of tumor tissue is solid tumor growth, cancer cells are well-differentiated; 2–6–50% of tissue is solid tumor growth, cancer cells are moderately differentiated; 3–more than 50% of tissue is solid tumor growth, cancer cells are poorly differentiated; NS, no significance.
Back to article page